NOMAD Biosensors from Innoprot
INNOPROT has developed a proprietary drug discovery technology platform for multiplexing GPCR screenings. This technology, called NOMAD Biosensors, uses different fluorescent biosensors to measure GPCRs’ different activation pathways in one single assay. Among NOMAD’s many advantages, you can easily evaluate G protein and β-arrestin modulation in the same assay, hence allowing biased activity studies. Four NOMAD biosensors are available for detection of Ca2+, cAMP, DAG or β-arrestin recruitment. Any combination of NOMAD biosensors can be co-expressed with the target tag-free GPCR, according to screening objectives.
Learn More on NOMAD Biosensors
Pages: 1 2